May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Incidence of Central Retinal Vein Occlusions in Patients on Systemic Anticoagulation with Aspirin or Warfarin
Author Affiliations & Notes
  • J. Tang
    Department of Ophthalmology, North Shore University Hospital, Great Neck, NY, United States
  • V.A. Deramo
    Department of Ophthalmology, North Shore University Hospital, Great Neck, NY, United States
  • Footnotes
    Commercial Relationships  J. Tang, None; V.A. Deramo, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4040. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Tang, V.A. Deramo; The Incidence of Central Retinal Vein Occlusions in Patients on Systemic Anticoagulation with Aspirin or Warfarin . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4040.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The purpose of this study was to evaluate the incidence of patients on systemic anticoagulation with aspirin or warfarin who presented with central retinal vein occlusions (CRVO). Methods: This was a retrospective consecutive case series in which we analyzed patients who were diagnosed with CRVO from January 2002 to December 2002. All patients were evaluated with best corrected Snellen visual acuity, biomicroscopy, and fluorescein angiography (FA) at the time of presentation. Baseline best corrected visual acuity, duration of symptoms, past medical/ocular history and use of anticoagulants were noted. Results: Twenty-four eyes of 24 patients who had a new diagnosis of CRVO were identified. Patients were symptomatic for 3 months on average prior to presentation. Of the 24 patients, 13 (54%) were female. The mean age was 69 years (range 26-95 years). Sixteen (66%) patients had preexisting hypertension, 4 (17%) patients had diabetes and 6 (25%) patients had high cholesterol by history. Five (20%) patients had open angle glaucoma. Nine (38%) of the 24 patients were on aspirin and 2 (8%) were on warfarin, both with therapeutic INR values (> 2.0) at the time of CRVO development. Seven (30%) of the 24 patients were treated with pan-retinal photocoagulation. Five (70%) of these 7 treated patients were on aspirin on presentation. Conclusions: Systemic anticoagulation with either aspirin or warfarin did not prevent the occurrence of CRVO in our study patients.

Keywords: vascular occlusion/vascular occlusive disease • retina • clinical (human) or epidemiologic studies: pre 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×